If Anavex is not a scam then it is certainly incompetently managed. There is nothing about Anavex to give serious investors confidence in management's ability to execute effectively. Look at the 3-year track record -- Completed one tiny, poorly designed trial in Australia resulting in ambiguous data, no collaborations, no new trials, and burning through $1MM+ a month. I'm sure as usual my opinion will be dissed and dismissed by the crowd but The God Doctor has ZERO credibility with investors or pharma. You don't have to believe me. Just look at the market cap. If you want a real shot at success, hope for a near-term change in leadership.
Market Data 
Markets 
AI
